Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Totus Medicines

Request full access

Designing life-changing medicines at genomic scale

United StatesFounded 2020Biotech & Life Sciences

About Totus Medicines

Totus Medicines is a pioneering biotech startup that leverages its proprietary platform to discover and develop drugs at an unprecedented scale, speed, and efficiency. The company operates in the pharmaceutical and biotechnology market, focusing on creating a comprehensive catalog of drugs targeting the entire human genome. This innovative approach allows Totus Medicines to design life-changing medicines, particularly for diseases that have been historically difficult to treat.

The core technology of Totus Medicines revolves around Power Covalent molecules. These molecules act as a universal key to unlock previously undruggable targets, which are proteins or genes that traditional drugs cannot effectively target. This method has been instrumental in developing some of the most effective therapeutics in history, such as penicillin and certain oncology drugs.

Totus Medicines primarily serves clients in the healthcare sector, including hospitals, clinics, and research institutions. Their breakthrough cancer drug, TOS 358, targets the PI 3 oncogene, which is highly mutated in various cancers like breast, colorectal, lung, and bladder cancer. This drug has shown promising results in inducing stasis and regression in PI 3 mutant models, addressing a significant unmet need in oncology.

The business model of Totus Medicines is based on drug discovery and development. They generate revenue through the commercialization of their proprietary drugs, partnerships with pharmaceutical companies, and potential licensing deals. By focusing on high-impact diseases such as cancer and heart disease, Totus Medicines aims to bring transformative treatments to market, thereby improving patient outcomes and generating substantial financial returns.

The leadership team, headed by Tom Hughes, PhD, brings extensive industry experience in drug discovery and development. Hughes has a proven track record, having held significant positions at Navitor Pharmaceuticals, Zafgen Inc., and Novartis.

Source: Dealroom company data

At a glance

Status
Operational
Employees
36
Open positions
None listed
Dealroom signal
74.7/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Drug Development, Biotech and Pharma, Techbio, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Dec 2023 $66M $264M DCVC ↗
SERIES AOther financing Dec 2021 $40M $160M DCVC · Northpond Ventures ↗
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Totus Medicines website traffic

Latest recorded traffic for Totus Medicines is 2.3K monthly website visits, up 27.8% over the last three months. Totus Medicines's team declined 5.3% over the past year.

Latest monthly visits2.3K 3-month web change+27.8% 1-year team growth-5.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Totus Medicines in its local ecosystem

Live from Dealroom

The Totus Medicines office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Social Impact Capital
  • DCVC
  • Northpond Ventures
Team profiled 11 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Totus Medicines on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Totus Medicines’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.